GE Healthcare is working alongside of Check-Cap on the development and validation of a cancer-screening process. Read More »

Portola Pharmaceuticals Inc.'s clinical results from a study will be presented during the International Conference on Malignant Lymphoma. Read More »

The American Society of Hospital Pharmacists (ASHP) recently announced that a new AHFS Drug Information (AHFS DI) has been released. Read More »

Envisia Therapeutics has released an interim analysis on the second cohort of its ENV515 (travoprost XR) Phase 2 trial, which involves patients with glaucoma. Read More »

Fred’s Inc.'s plans to buy 865 Rite Aid stores for $950 million is still active. Read More »

Zimmer Biomet Holdings' Gel-One Cross-linked Hyaluronate has been approved by the U.S. Food and Drug Administration. Read More »

Amgen recently shared positive results for its Fourier Trial, which is evaluating whether Repatha reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease. Read More »

The cost of generic prescription drugs rose at a much slower rate than brand name drugs in 2016, according to an annual national drug index released by Truveris. Read More »

CVS Health will nationally sponsor the American Heart Association’s Go Red For Women and pledge to raise $10 million over the next three years in support of life-saving cardiovascular research and education. Read More »

The U.S. Food and Drug Administration has approved Siliq (brodalumab) as a treatment for adults with moderate-to-severe plaque psoriasis. Read More »

Advanced Pharma Inc., which does business as Avella of Houston, is voluntarily recalling unexpired sterile injectable products labeled "latex free" that were produced at the company’s Houston location between Sep. 1, 2016 and Feb. 16, 2017. Read More »

The Academy of Managed Care Pharmacy's members are urging Congress and President Donald Trump's administration to include comprehensive pharmacy benefits in any health care reform bill they attempt to pass. Read More »

Valeant Pharmaceuticals Inc. and EyeGate Pharmaceuticals have entered an exclusive, global licensing agreement. Read More »

A patent application has been filed for a new cannabinoid-based topical therapy that will treat glaucoma, the second-leading cause of blindness. Read More »

Allegra drug developer Sanofi supports Bike to Work Day, a day where Americans are urged to ride bicycles to work instead of driving. Read More »

The first new drug approved specifically to treat amyotrophic lateral sclerosis (ALS), commonly referred to a Lou Gehrig’s Disease, in over two decades was approved in less than a year, thanks in large part to the FDA working in conjunction with Mitsubishi Tanabe Pharma Corp. and the ALS Association. Read More »

The Food and Drug Administration has approved Genentech's Lucentis as a treatment for all forms of diabetic retinopathy, the leading cause of blindness among working age adults in the country. Read More »

Waismann Method Medical Group directors have warned of a new naloxone-resistant drug hitting the streets, calling for an awareness program for acrylfentanyl and warning of a serious public health emergency. Read More »

Eight real-world analyses regarding Entyvio (vedolizumab) for treating adults with moderate to severe ulcerative colitis and Crohn's disease were presented at the 2017 Digestive Disease Week annual scientific meeting. Read More »

GSK has made a $139 million investment in a biopharmaceutical manufacturing site in Rockville, Maryland. Read More »